Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Twenty Years of PSA: From Prostate Antigen to Tumor Marker.

Literature DB >> 17934568

Twenty Years of PSA: From Prostate Antigen to Tumor Marker.

Gabriela De Angelis, Harry G Rittenhouse, Stephen D Mikolajczyk, L Blair Shamel, Axel Semjonow.

Abstract

The measurement of prostate-specific antigen in serum is credited with dramatic advances in the early detection of men with prostatic carcinoma. This report summarizes the history of biochemical research and the current understanding and application of prostate-specific antigen in prostate cancer diagnostics.

Entities: Disease Gene Species

Keywords: Human kallikrein; Immunoassays; Prostate cancer; Prostate-specific antigen

Year: 2007 PMID： 17934568 PMCID： PMC2002501

Source DB: PubMed Journal: Rev Urol ISSN： 1523-6161

104 in total

1. Primary structure of a human glandular kallikrein gene.

Authors: L J Schedlich; B H Bennetts; B J Morris
Journal: DNA Date: 1987-10

2. Ala217 is important for the catalytic function and autoactivation of prostate-specific human kallikrein 2.

Authors: S D Mikolajczyk; L S Millar; K M Marker; L S Grauer; A Goel; M M Cass; A Kumar; M S Saedi
Journal: Eur J Biochem Date: 1997-06-01

3. Screening with low PSA cutoff values results in low rates of positive surgical margins in radical prostatectomy specimens.

Authors: Andreas P Berger; Hubert Volgger; Hermann Rogatsch; Dagmar Strohmeyer; Hannes Steiner; Helmut Klocker; Georg Bartsch; Wolfgang Horninger
Journal: Prostate Date: 2002-11-01 Impact factor: 4.104

4. Identification of precursor forms of free prostate-specific antigen in serum of prostate cancer patients by immunosorption and mass spectrometry.

Authors: J Peter; C Unverzagt; T N Krogh; O Vorm; W Hoesel
Journal: Cancer Res Date: 2001-02-01 Impact factor: 12.701

5. Comparative analysis of complexed prostate specific antigen, free prostate specific antigen and their ratio in detecting prostate cancer.

Authors: Koji Okihara; Carol D Cheli; Alan W Partin; Herbert A Fritche; Daniel W Chan; Lori J Sokoll; Michael K Brawer; Morton K Schwartz; Robert L Vessella; Kevin R Loughlin; Dennis A Johnston; R Joseph Babaian
Journal: J Urol Date: 2002-05 Impact factor: 7.450

6. DD3: a new prostate-specific gene, highly overexpressed in prostate cancer.

Authors: M J Bussemakers; A van Bokhoven; G W Verhaegh; F P Smit; H F Karthaus; J A Schalken; F M Debruyne; N Ru; W B Isaacs
Journal: Cancer Res Date: 1999-12-01 Impact factor: 12.701

7. Enzymatic activity of prostate-specific antigen and its reactions with extracellular serine proteinase inhibitors.

Authors: A Christensson; C B Laurell; H Lilja
Journal: Eur J Biochem Date: 1990-12-27

8. Identity of prostate specific antigen and the semen protein P30 purified by a rapid chromatography technique.

Authors: H C Graves; M Kamarei; T A Stamey
Journal: J Urol Date: 1990-12 Impact factor: 7.450

9. Serum prostate-specific antigen in a community-based population of healthy men. Establishment of age-specific reference ranges.

Authors: J E Oesterling; S J Jacobsen; C G Chute; H A Guess; C J Girman; L A Panser; M M Lieber
Journal: JAMA Date: 1993-08-18 Impact factor: 56.272

10. uPM3, a new molecular urine test for the detection of prostate cancer.

Authors: Yves Fradet; Fred Saad; Armen Aprikian; Jean Dessureault; Mostafa Elhilali; Claude Trudel; Benoît Mâsse; Lyson Piché; Camille Chypre
Journal: Urology Date: 2004-08 Impact factor: 2.649

25 in total

1. Bar-coded hydrogel microparticles for protein detection: synthesis, assay and scanning.

Authors: David C Appleyard; Stephen C Chapin; Rathi L Srinivas; Patrick S Doyle
Journal: Nat Protoc Date: 2011-10-20 Impact factor: 13.491

2. Secretory phospholipase A2-IIa is a target gene of the HER/HER2-elicited pathway and a potential plasma biomarker for poor prognosis of prostate cancer.

Authors: Leslie Oleksowicz; Yin Liu; R Bruce Bracken; Krishnanath Gaitonde; Barbara Burke; Paul Succop; Linda Levin; Zhongyun Dong; Shan Lu
Journal: Prostate Date: 2011-11-29 Impact factor: 4.104

Review 3. Droplet microfluidics for high-sensitivity and high-throughput detection and screening of disease biomarkers.

Authors: Aniruddha M Kaushik; Kuangwen Hsieh; Tza-Huei Wang
Journal: Wiley Interdiscip Rev Nanomed Nanobiotechnol Date: 2018-05-24

4. Optimism and prostate cancer-specific expectations predict better quality of life after robotic prostatectomy.

Authors: Andrea A Thornton; Martin A Perez; Sindy Oh; Laura Crocitto
Journal: J Clin Psychol Med Settings Date: 2012-06

5. Prostate cancer risk alleles significantly improve disease detection and are associated with aggressive features in patients with a "normal" prostate specific antigen and digital rectal examination.

Authors: Brian T Helfand; Donghui Kan; Parth Modi; William J Catalona
Journal: Prostate Date: 2010-09-21 Impact factor: 4.104